Jupiter Life Lin

FY26 was a momentous year for Jupiter Life Line Hospitals, highlighted by the inauguration of the Dombivli greenfield hospital in February. This 500-bed facility, with approximately 300 beds fitted out, was commissioned ahead of its Q1 FY27 target. The project was completed in just over 24 months, covering 750,000 sq ft, without any cost escalations or budget surprises. Management expressed confidence in achieving the guided year 2 breakeven for Dombivli, with initial response from doctors and the local community being very encouraging.

Beyond Dombivli, Jupiter is actively advancing other key expansion projects. Pune South remains on track for an opening in calendar year '28, as committed. Mira Road has completed its architectural drawings and is undergoing regulatory clearances, with excavation expected to commence by the end of the year. A significant strategic project is the planned 400-bed quaternary care hospital in BKC, Mumbai, on over 1 lakh square feet of land, which management views as a declaration of Jupiter's readiness to compete at the highest levels. These projects contribute to an expansion cycle of approximately 1,700 new beds, bringing the company's long-term capacity to nearly 3,000 beds.

For the full financial year 2026, Jupiter Life Line Hospitals reported a total income of INR1,499.8 crores, marking a 15.2% year-on-year increase. EBITDA for FY26 came in at INR343.3 crores, up 14.4%, with margins maintained at 22.9%. The company's PAT for the full year stood at INR194.2 crores. In the fourth quarter, revenue was INR387.8 crores, a 15.1% increase, with EBITDA at INR89.2 crores, representing a 23% margin, and PAT at INR50.2 crores, up 11.5%.

Key operational metrics demonstrated strong performance, with Average Revenue Per Occupied Bed (ARPOB) growing 11.7% to INR67,700. The Average Length of Stay (ALOS) was 3.87 days, and the bed occupancy for the three pre-existing hospitals (Thane, Pune, and Indore) stood at 61.2%. Overall volumes increased by 9.9% to 10.8 lakhs, driven by growth in both outpatient and inpatient numbers. Insurance revenues now constitute 55.4% of the revenue mix, while government schemes account for 1%.

Jupiter deployed approximately INR500 crores in capex during FY26, allocated to Dombivli, BKC land payment, and ongoing Pune and Mira Road projects. Despite this significant investment, the company remains net cash positive, with gross debt around INR500 crores and cash on hand at INR545 crores. Management stated that internal accruals over the next 4-odd years, combined with debt maintained under 3 times EBITDA, are expected to be sufficient to fund all announced projects, including the 1,700 new beds at an average cost of INR1.5 crores per bed.

The Indore facility is currently in its ramp-up phase, with occupancy rates between 45% and 50%. Management noted that the maturing of Indore and improvement in its case mix significantly contributed to the overall ARPOB growth. The company plans to consider the second phase of Indore expansion, which involves adding 111 beds, once the current occupancy crosses 60% or nears that level, indicating a strategic approach to capacity utilization.

Jupiter Life Line Hospitals maintains a clear strategic focus on catering to local residential communities, with very limited reliance on international medical tourism. Management emphasized that their hospital model is designed to serve the immediate 45-minute driving distance community. They do not find international medical tourism to be significantly margin accretive or necessary, given the robust local demand, and prefer to concentrate on domestic and local patient services.